Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Ero Copper | ERO | 6. nov 2024 | 17.08 | -8.27 |
ESAB | ESAB | 6. nov 2024 | 133.11 | +5.06 |
Escalade | ESCA | 6. nov 2024 | 15.27 | +7.01 |
Esco Technologies | ESE | 6. nov 2024 | 142.65 | +9.17 |
ESGL | ESGL | 6. nov 2024 | 1.79 | -2.20 |
ESH Acquisition | ESHA | 6. nov 2024 | 10.69 | 0.00 |
Eshallgo | EHGO | 6. nov 2024 | 3.01 | -19.95 |
Esperion Therapeutics | ESPR | 6. nov 2024 | 2.21 | +4.25 |
Espey Mfg & Electronics | ESP | 6. nov 2024 | 32.20 | -1.68 |
Esquire Financial | ESQ | 6. nov 2024 | 73.86 | +8.68 |
ESS Tech | GWH | 6. nov 2024 | 8.16 | -5.34 |
ESSA Bancorp | ESSA | 6. nov 2024 | 20.75 | +6.79 |
ESSA Pharma | EPIX | 6. nov 2024 | 1.71 | +0.59 |
Essent Group | ESNT | 6. nov 2024 | 56.43 | +5.18 |
Essential Properties Realty Trust | EPRT | 6. nov 2024 | 31.67 | -0.41 |
Essential Utilities | WTRG | 6. nov 2024 | 40.35 | +0.57 |
Essex Property Trust | ESS | 6. nov 2024 | 293.76 | +0.95 |
Establishment Labs | ESTA | 6. nov 2024 | 48.81 | +1.90 |
Estee Lauder Companies | EL | 6. nov 2024 | 63.28 | -3.92 |
Estrella Immunopharma | ESLA | 6. nov 2024 | 0.79 | -7.04 |
Eterna Therapeutics | ERNA | 6. nov 2024 | 1.12 | 0.00 |
ETFMG Alternative Harvest ETF | MJ | 6. nov 2024 | 2.73 | -17.77 |
Ethan Allen Interiors | ETD | 6. nov 2024 | 28.76 | +2.79 |
Eton Pharmaceuticals | ETON | 6. nov 2024 | 8.67 | +2.97 |
Etsy | ETSY | 6. nov 2024 | 53.08 | +0.66 |
Euda Health | EUDA | 6. nov 2024 | 3.99 | -9.52 |
Eupraxia Pharmaceuticals | EPRX | 6. nov 2024 | 3.11 | -5.37 |
Eureka Acquisition | EURKU | 6. nov 2024 | 10.40 | 0.00 |
Eureka Acquisition | EURK | 6. nov 2024 | 10.10 | 0.00 |
Euro Tech Holdings | CLWT | 6. nov 2024 | 1.50 | +0.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.